JHS Svendgaard Laboratories Limited
NSE:JHS.NS
22.69 (INR) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 707.982 | 962.067 | 854.914 | 1,000.724 | 1,384.959 | 1,232.665 | 1,389.568 | 1,054.785 | 1,000.855 | 553.239 | 352.796 | 595.906 | 1,266.02 | 1,276.954 | 684.583 | 279.943 | 363.75 | 318.641 |
| Cost of Revenue
| 597.127 | 658.675 | 605.332 | 684.176 | 997.522 | 870.553 | 902.742 | 685.301 | 731.922 | 403.993 | 206.513 | 249.975 | 928.031 | 909.84 | 407.625 | 136.381 | 230.021 | 225.599 |
| Gross Profit
| 110.855 | 303.392 | 249.582 | 316.548 | 387.437 | 362.112 | 486.826 | 369.484 | 268.933 | 149.247 | 146.283 | 345.931 | 337.989 | 367.114 | 276.959 | 143.562 | 133.73 | 93.042 |
| Gross Profit Ratio
| 0.157 | 0.315 | 0.292 | 0.316 | 0.28 | 0.294 | 0.35 | 0.35 | 0.269 | 0.27 | 0.415 | 0.581 | 0.267 | 0.287 | 0.405 | 0.513 | 0.368 | 0.292 |
| Reseach & Development Expenses
| 0 | 0.653 | 0.654 | 0.014 | 0.372 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 94.799 | 45.748 | 16.933 | 17.569 | 21.222 | 21.156 | 18.996 | 18.772 | 13.54 | 20.99 | 19.954 | 15.214 | 0 | 92.956 | 72.525 | 50.82 | 39.014 | 17.064 |
| Selling & Marketing Expenses
| 2.845 | 28.298 | 6.985 | 6.53 | 61.427 | 38.082 | 32.614 | 7.359 | 8.26 | 6.561 | 3.509 | 13.338 | 0 | 0 | 0 | 0 | 0 | 4.803 |
| SG&A
| 97.644 | 74.046 | 23.918 | 24.099 | 82.649 | 59.238 | 51.61 | 26.131 | 21.801 | 27.551 | 129.357 | 143.196 | 0 | 92.956 | 72.525 | 50.82 | 39.014 | 21.866 |
| Other Expenses
| 266.444 | 143.977 | 35.171 | 15.78 | 22.505 | 6.949 | 3.304 | 302.389 | 278.574 | 3.319 | 33.991 | 124.427 | 60.385 | 95.996 | 85.471 | 49.437 | 26.791 | 11.184 |
| Operating Expenses
| 183.685 | 469.05 | 299.831 | 279.828 | 415.816 | 375.837 | 401.686 | 328.52 | 300.375 | 303.877 | 331.921 | 364.215 | 243.515 | 188.951 | 157.996 | 100.257 | 65.806 | 33.05 |
| Operating Income
| 0 | -69.817 | -41.869 | 3.554 | -29.155 | -31.831 | 85.14 | 40.964 | -31.442 | -154.63 | -185.638 | -18.284 | 94.474 | 178.163 | 118.962 | 43.305 | 67.924 | 59.991 |
| Operating Income Ratio
| 0 | -0.073 | -0.049 | 0.004 | -0.021 | -0.026 | 0.061 | 0.039 | -0.031 | -0.279 | -0.526 | -0.031 | 0.075 | 0.14 | 0.174 | 0.155 | 0.187 | 0.188 |
| Total Other Income Expenses Net
| -34.286 | -159.635 | -132.171 | -187.43 | -273.394 | -3.294 | 299.096 | -3.02 | -184.953 | -74.396 | -198.835 | 3.477 | -53.871 | -20.86 | -29.964 | -29.519 | -27.465 | -11.752 |
| Income Before Tax
| -34.286 | -218.402 | 1.03 | 9.678 | -58.43 | -20.45 | 384.236 | 51.726 | -216.395 | -221.326 | -352.974 | 3.096 | 32.568 | 141.024 | 88.998 | 13.786 | 40.458 | 48.239 |
| Income Before Tax Ratio
| -0.048 | -0.227 | 0.001 | 0.01 | -0.042 | -0.017 | 0.277 | 0.049 | -0.216 | -0.4 | -1.001 | 0.005 | 0.026 | 0.11 | 0.13 | 0.049 | 0.111 | 0.151 |
| Income Tax Expense
| 6.291 | -50.649 | 43.924 | -3.746 | -9.88 | -3.777 | 123.691 | -167.959 | 0.016 | 0.442 | -64.877 | 40.709 | 21.485 | 18.926 | 8.752 | -0.048 | 4.94 | 4.501 |
| Net Income
| -40.577 | -154.638 | -40.52 | 11.982 | -19.791 | -6.806 | 261.492 | 219.686 | -216.411 | -221.768 | -288.097 | -37.613 | 11.084 | 122.099 | 80.246 | 13.834 | 35.518 | 43.738 |
| Net Income Ratio
| -0.057 | -0.161 | -0.047 | 0.012 | -0.014 | -0.006 | 0.188 | 0.208 | -0.216 | -0.401 | -0.817 | -0.063 | 0.009 | 0.096 | 0.117 | 0.049 | 0.098 | 0.137 |
| EPS
| -0.52 | -2.38 | -0.63 | 0.2 | -0.32 | -0.11 | 4.29 | 5.45 | -8.42 | -9.2 | -11.96 | -1.56 | 0.66 | 8.41 | 5.86 | 1.07 | 2.84 | 4.93 |
| EPS Diluted
| -0.52 | -2.38 | -0.63 | 0.19 | -0.32 | -0.11 | 4.29 | 3.69 | -8.42 | -9.2 | -11.96 | -1.56 | 0.65 | 8.41 | 5.55 | 1.06 | 2.84 | 4.93 |
| EBITDA
| 33.776 | -163.819 | 28.653 | 94.569 | 46.614 | 60.293 | 143.457 | 121.11 | 74.142 | -30.165 | -82.171 | 117.97 | 160.184 | -96.062 | 160.42 | 73.754 | 69.937 | 66.047 |
| EBITDA Ratio
| 0.048 | 0.055 | 0.097 | 0.133 | 0.111 | 0.065 | 0.13 | 0.1 | 0.074 | -0.055 | 0.074 | 0.198 | 0.132 | 0.194 | 0.234 | 0.263 | 0.24 | 0.207 |